{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled \"Gluten in Drug Products and Associated Labeling Recommendations.\" This draft guidance is intended to convey to drug manufacturers FDA's recommendations on how certain oral drug products should be labeled regarding gluten, a matter of interest to individuals with celiac disease. Some individuals with celiac disease have faced difficulty when trying to determine whether specific drug products contain gluten. This draft guidance encourages drug manufacturers to have accurate information about their products' gluten content available so they can respond to questions from consumers and health care professionals.","action":"Notice of availability.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2017/12/13/2017-26828.html","cfr_references":[],"citation":"82 FR 58618","comment_url":null,"comments_close_on":"2018-02-12","correction_of":null,"corrections":[],"dates":"Submit either electronic or written comments on the draft guidance by February 12, 2018 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance.","disposition_notes":null,"docket_ids":["Docket No. FDA-2017-D-6352"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":87,"comment_start_date":"2017-12-13","updated_at":"2023-02-28T21:34:33.877-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2017-D-6352-0001","allow_late_comments":null,"id":"FDA-2017-D-6352-0001","comment_end_date":"2018-02-13","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2017-D-6352","title":"Gluten in Drug Products and Associated Labeling Recommendations"}],"document_number":"2017-26828","effective_on":null,"end_page":58619,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2017/12/13/2017-26828.xml","html_url":"https://www.federalregister.gov/documents/2017/12/13/2017-26828/gluten-in-drug-products-and-associated-labeling-recommendations-draft-guidance-for-industry","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2017-26828?publication_date=2017-12-13","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2017-12-13/2017-26828/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":828,"last_updated":"2026-11-22 06:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2017-12-13/pdf/2017-26828.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2017-26828.pdf?1513086355","publication_date":"2017-12-13","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2017/12/13/2017-26828.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":87,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2017-D-6352","supporting_documents_count":0,"docket_id":"FDA-2017-D-6352","document_id":"FDA-2017-D-6352-0001","regulation_id_number":null,"title":"Gluten in Drug Products and Associated Labeling Recommendations","checked_regulationsdotgov_at":"2023-03-01T02:34:32Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":58618,"subtype":null,"title":"Gluten in Drug Products and Associated Labeling Recommendations; Draft Guidance for Industry; Availability","toc_doc":"Gluten in Drug Products and Associated Labeling Recommendations","toc_subject":"Guidance:","topics":[],"type":"Notice","volume":82}